News list for "hera"
Nasdaq-listed company Leap Therapeutics announced the purchase of 203,775.27 ZEC tokens at an average price of $245 per token and announced its transformation into a ZEC treasury. The company has changed its name to Cypherpunk Technologies Inc. In addition, the company also announced a $58.88 million private placement led by Winklevoss Capital.
纳斯达克上市公司Leap Therapeutics宣布以每枚代币245美元的平均价格购买203,775.27枚ZEC代币并宣布转型为ZEC财库公司已更名为 Cypherpunk Technologies Inc.，此外该公司还宣布获得Winklevoss Capital领投的5888万美元私募融资。
Biotech company Leap Therapeutics (NASDAQ: LPTX) today announced that it has completed a previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to launch a digital asset finance strategy. Winklevoss Capital will provide funding and strategic support to help Leap structure and execute its digital asset finance strategy. Under the lead investor agreement, Leap's board of directors will increase to 12 members, and Winklevoss Capital will have the right to nomi...
生物技术公司 Leap Therapeutics（纳斯达克股票代码：LPTX）今天宣布，它已经完成之前宣布的由 Winklevoss Capital 领投的私募，筹集 58,888,888 美元现金，以启动数字资产财务战略。 Winklevoss Capital 将提供资金和战略支持，帮助 Leap 构建并执行其数字资产财务战略。根据牵头投资者协议，Leap 董事会成员增至 12 名，Winklevoss Capital 将有权提名两名个人进入 Leap 董事会，其中一人还将担任董事会主席。 Morgan, Lewis & ...
Nasdaq plans to delist BNB treasury company Windtree Therapeutics (ticker: WINT) after failing to comply with Nasdaq Listing Rule 5550 (a) (2), which requires minimum bids for shares to remain above $1. Windtree confirmed its non-compliance in a filing with the Securities Supervision Commission.
纳斯达克计划摘牌BNB财库公司Windtree Therapeutics（股票代码：WINT），原因是公司未能遵守纳斯达克上市规则5550(a)(2)——即股票最低竞价需维持在1美元以上。Windtree在向美国证监会提交的文件中确认了其不合规状况。
Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced that it has signed a common stock purchase agreement of up to $500 million to establish an equity credit line (ELOC), in addition to an additional stock purchase agreement valued at $20 million with Build and Build Corp. The total financing size is up to $520 million, of which 99% will be used to purchase BNB. The company plans to officially start using funds after obtaining shareholder approval to increase the number of common...
纳斯达克上市生物技术公司 Windtree Therapeutics（WINT）宣布，已签署最多 5 亿美元的普通股购买协议，用于建立股权信用额度（ELOC），此外，该公司还与 Build and Build Corp 签署了一份价值 2000 万美元的额外股票购买协议。 此次总融资规模最高达 5.2 亿美元，其中 99% 的资金将用于购买 BNB。公司计划在获得股东批准增加普通股授权数量后正式启动资金动用。
Nasdaq-listed Sonnet BioTherapeutics, Inc. has agreed to merge with Rorschach I LLC to form Hyperliquid Strategies, Inc., which will initiate a HYPE reserve strategy. Upon completion of the transaction, the new entity is expected to hold 12.60 million HYPE tokens and $305 million in cash for a total valuation of $888 million.
纳斯达克上市公司 Sonnet BioTherapeutics, Inc. 已同意与 Rorschach I LLC 合并成为 Hyperliquid Strategies, Inc.，该公司将启动HYPE储备策略，交易完成后新实体预计将持有 1260 万个 HYPE 代币和 3.05 亿美元现金，总估值为 8.88 亿美元。
